Clinical Trials Sponsored by Instituto Bernabeu

Total 74003 results

Rafael Bernabeu Pérez

Unknown

New Device to Maintain the Embryo Temperature During Transfer (EmbryoTemp)

Embryo Transfer

Spain
Instituto Bernabeu

Not yet recruiting

Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. (PRO_NAT)

IVF
Instituto Bernabeu

Terminated

Random-start Ovarian Stimulation in Egg-donors (ROSE) (ROSE)

Infertility

Spain
Instituto Bernabeu

Unknown

Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial) (LUTEAL)

Reproductive Techniques, Assisted

Spain
Instituto Bernabeu

Recruiting

Comparison of Triggers in Double Ovarian Stimulation (DuoStim). (COTRID)

IVF | LOW OVARIAN RESPONSE

Spain
Instituto Bernabeu

Completed

Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor (TAIL)

Ovarian Stimulation

Spain
Instituto Bernabeu

Completed

Validation of a NICS Method Using the Culture Medium

Chromosome Abnormality | Abnormality

Spain
Instituto Bernabeu

Unknown

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON)

Reproductive Techniques, Assisted

Spain
Instituto Bernabeu

Not yet recruiting

TRAP Study: Testosterone for Androgen Receptor Polymorphism (TRAP)

Fertility Disorders

Spain
Instituto Bernabeu

Recruiting

Continuous Double Ovarian Stimulation.

Fertility Issues

Spain
Instituto Bernabeu

Recruiting

Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment

Fertility Disorders

Spain
Instituto Bernabeu

Completed

Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response (SUBLUTEAL)

Improving Ovarian Stimulation; Suboptimal Responders

Spain
Instituto Bernabeu

Completed

Vaginal Microbiome Influence on the Results of Assisted Reproduction Techniques (RIFMicrobiome)

Implantation Failure

Spain
Instituto Bernabeu

Terminated

Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Gestation (PROdE) (PROdE)

Placenta; Implantation

Spain
Instituto Bernabeu

Completed

Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer. (CycloCT)

Luteal Phase Defect

Spain
Instituto Bernabeu

Completed

Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients

Infertility

Spain
Peter Humaidan
Instituto Bernabeu

Completed

The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors

Bacterial Vaginoses

Spain
Instituto Bernabeu
Universidad Miguel Hernandez de Elche

Recruiting

Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle (Compaction)

Infertility Due to Nonimplantation

Spain
University of Valencia
Juan Carlos Bernabeu Mira; Miguel Peñarrocha Diago

Completed

Comparison Between High-speed Drilling With Irrigation and Low-speed Drilling With Irrigation

Bone Loss

Spain
University of Illinois at Chicago
Lisa Tussing-Humphreys; Ardith Doorenbos; Beatriz Peñalver Bernabé; Mario Spaggiari and other collaborators

Recruiting

The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation (BIOME-KT)

Gut Microbiome | Kidney Transplant Symptoms

United States
Brigham and Women's Hospital
Socios En Salud Sucursal, Peru; Hospital Nacional Arzobispo Loayza; Hospital... and other collaborators

Unknown

Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission (FAST)

Tuberculosis

Peru
Charite University, Berlin, Germany
German Federal Ministry of Education and Research; University of Potsdam; Brandenburg...

Unknown

TDCS in Acute Stroke (TDCS-aphasia)

Stroke

Germany
Butantan Institute
InCor - Instituto do Coração - HCFMUSP.

Withdrawn

Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes

Rheumatic Fever
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Frailty Syndrome

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain

Brain Lesion (General)

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure

Renal Failure

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure

Ischemic Congestive Heart Failure

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction (Acute MI)

Acute Myocardial Infarction

United States
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke

Stroke

Mexico
Instituto de Investigação em Imunologia
Butantan Institute

Unknown

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Cancer. | Melanoma. | Ovarian Cancer. | Lung Cancer.

Brazil
Institut Curie
National Cancer Institute, France

Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) (LOC-R01)

Lymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, Primary

France
Institut Bergonié
National Cancer Institute, France

Completed

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial (FRAIL-06)

Lymphoma

France
Institut Bergonié
National Cancer Institute, France

Completed

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer (HORGEN)

Breast Cancer

France
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
Jules Bordet Institute
AstraZeneca; Institut Curie

Active, not recruiting

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (Neo-CheckRay)

Luminal B

France, Belgium
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
Institut Bergonié
National Cancer Institute, France

Completed

Validation of a Screening Tool in Geriatric Oncology (ONCODAGE)

Lymphoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

France
Institut Bergonié

Completed

Effect of Advertisements on Treatment Compliance in Women With Breast Cancer

Breast Cancer
Institut Curie

Completed

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

France
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Institut Bergonié

Completed

Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer

Pain | Breast Cancer | Psychosocial Effects of Cancer and Its Treatment
Institut Curie

Unknown

Study of Tumor and Blood Samples From Women With Breast Cancer

Breast Cancer

France
Institut Bergonié

Unknown

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Institut Curie

Unknown

Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer

Breast Cancer | Metastatic Cancer

France
Institut Guttmann
Instituto de Salud Carlos III

Completed

Non-invasive Brain Stimulation for Gait Improvement in Patients With Spinal Cord Injury (SCI)

Functional Improvement
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Adipose Derived Stem Cell Therapy for Autism

Autism

United States
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure

Non-Ischemic Congestive Heart Failure

Mexico
Institut Curie
National Cancer Institute, France

Completed

ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery (ER-One)

Breast Surgery

France
Institut Bergonié
National Cancer Institute, France

Completed

A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (RADIOSARP)

Soft-tissue Sarcoma

France
Institut Curie

Completed

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Breast Cancer

France

3

Subscribe